Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Analysis of Profitability Ratios
Quarterly Data

Microsoft Excel

Profitability Ratios (Summary)

DexCom Inc., profitability ratios (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Return on Sales
Gross profit margin 63.87% 63.94% 64.44% 64.72% 64.97% 66.10% 67.44% 68.63% 69.29% 69.15% 67.48% 66.44% 65.38% 63.92% 63.68% 63.11% 62.54% 62.76% 63.30% 64.36%
Operating profit margin 14.88% 14.02% 13.14% 13.44% 9.54% 8.87% 10.15% 10.86% 15.92% 15.90% 15.39% 15.54% 16.31% 15.09% 11.89% 9.64% -9.16% -13.58% -15.07% -18.06%
Net profit margin 11.08% 11.18% 9.68% 11.73% 8.24% 7.47% 8.23% 6.32% 22.82% 24.45% 25.36% 25.62% 12.69% 11.93% 9.24% 6.85% -12.68% -13.96% -11.51% -12.32%
Return on Investment
Return on equity (ROE) 16.62% 17.02% 13.10% 16.01% 12.61% 8.85% 9.67% 6.87% 24.78% 26.56% 27.01% 27.02% 15.41% 15.12% 15.83% 11.45% -22.41% -24.77% -19.41% -19.16%
Return on assets (ROA) 5.72% 5.24% 5.30% 6.33% 4.69% 3.83% 4.19% 3.18% 11.08% 11.78% 11.71% 11.50% 6.03% 5.81% 6.04% 4.22% -7.84% -8.25% -6.58% -6.63%

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. DexCom Inc. gross profit margin ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. DexCom Inc. operating profit margin ratio improved from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. DexCom Inc. net profit margin ratio improved from Q1 2023 to Q2 2023 but then slightly deteriorated from Q2 2023 to Q3 2023.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. DexCom Inc. ROE improved from Q1 2023 to Q2 2023 but then slightly deteriorated from Q2 2023 to Q3 2023.
ROA A profitability ratio calculated as net income divided by total assets. DexCom Inc. ROA deteriorated from Q1 2023 to Q2 2023 but then improved from Q2 2023 to Q3 2023 exceeding Q1 2023 level.

Gross Profit Margin

DexCom Inc., gross profit margin calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in thousands)
Gross profit 623,300 546,400 462,600 541,300 494,200 449,500 398,100 472,600 446,900 417,100 343,900 399,100 340,400 284,100 256,500 309,300 246,900 206,500 168,800 222,800 168,600 153,600 118,900
Revenue 975,000 871,300 741,500 815,200 769,600 696,200 628,800 698,200 650,200 595,100 505,000 568,900 500,900 451,800 405,100 462,800 396,300 336,400 280,500 338,000 266,700 242,500 184,400
Profitability Ratio
Gross profit margin1 63.87% 63.94% 64.44% 64.72% 64.97% 66.10% 67.44% 68.63% 69.29% 69.15% 67.48% 66.44% 65.38% 63.92% 63.68% 63.11% 62.54% 62.76% 63.30% 64.36%
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories 49.97% 50.23% 50.66% 51.54% 52.60% 53.54% 52.44% 52.21% 52.01% 50.69% 51.25% 50.49% 50.18% 50.97% 52.13% 52.46%
Cigna Group 12.28% 12.19% 12.39% 12.44% 12.39% 12.40% 12.30% 12.41% 12.77% 13.13% 14.04% 14.43% 15.05% 15.49% 15.30% 15.57%
CVS Health Corp. 15.34% 15.69% 16.16% 16.62% 16.94% 17.12% 17.35% 17.48% 17.35% 17.43% 17.99% 18.01% 18.10% 18.16% 17.51% 17.41%
Elevance Health Inc. 16.86% 16.89% 16.90% 16.79% 16.85% 16.79% 16.89% 17.09% 17.30% 17.57% 19.38% 19.71% 20.18% 20.43% 18.70% 18.77%
Intuitive Surgical Inc. 66.61% 66.74% 66.86% 67.44% 67.77% 68.16% 68.84% 69.32% 69.12% 68.69% 66.48% 65.65% 66.44% 67.07% 69.04% 69.45%
Medtronic PLC 66.43% 67.21% 67.61% 67.98% 67.89% 67.39% 66.53% 65.19% 63.85% 64.57% 65.76% 67.41% 68.96% 69.22% 69.62% 70.04%
UnitedHealth Group Inc. 24.16% 24.08% 24.20% 24.09% 23.74% 23.51% 23.31% 23.60% 23.75% 23.80% 25.79% 25.62% 25.83% 25.95% 23.52% 23.19%

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Gross profit margin = 100 × (Gross profitQ3 2023 + Gross profitQ2 2023 + Gross profitQ1 2023 + Gross profitQ4 2022) ÷ (RevenueQ3 2023 + RevenueQ2 2023 + RevenueQ1 2023 + RevenueQ4 2022)
= 100 × (623,300 + 546,400 + 462,600 + 541,300) ÷ (975,000 + 871,300 + 741,500 + 815,200) = 63.87%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. DexCom Inc. gross profit margin ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.

Operating Profit Margin

DexCom Inc., operating profit margin calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in thousands)
Operating income (loss) 205,500 128,100 47,200 125,400 147,500 77,000 41,300 600 118,300 101,000 45,900 104,000 94,100 67,800 33,600 101,500 56,000 (800) (14,400) (164,600) 13,900 (4,900) (30,700)
Revenue 975,000 871,300 741,500 815,200 769,600 696,200 628,800 698,200 650,200 595,100 505,000 568,900 500,900 451,800 405,100 462,800 396,300 336,400 280,500 338,000 266,700 242,500 184,400
Profitability Ratio
Operating profit margin1 14.88% 14.02% 13.14% 13.44% 9.54% 8.87% 10.15% 10.86% 15.92% 15.90% 15.39% 15.54% 16.31% 15.09% 11.89% 9.64% -9.16% -13.58% -15.07% -18.06%
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories 15.02% 15.23% 16.77% 19.16% 20.95% 22.42% 20.73% 19.56% 20.04% 18.46% 17.97% 15.48% 13.39% 12.78% 14.18% 14.21%
Cigna Group 4.34% 4.38% 4.54% 4.69% 4.59% 4.71% 4.64% 4.60% 4.59% 4.57% 4.98% 5.12% 5.37% 5.47% 5.18% 5.31%
CVS Health Corp. 4.04% 1.88% 2.33% 2.41% 2.02% 4.35% 4.39% 4.54% 4.75% 4.93% 5.19% 5.19% 5.44% 5.36% 4.89% 4.69%
Elevance Health Inc. 4.58% 4.96% 4.99% 4.94% 5.01% 5.07% 5.10% 5.15% 4.91% 3.68% 4.83% 4.97% 5.59% 6.99% 5.47% 5.49%
Humana Inc. 4.42% 4.55% 4.45% 4.11% 4.09% 3.57% 3.73% 3.80% 3.40% 4.97% 6.60% 6.56% 7.77% 6.77% 5.09% 4.96%
Intuitive Surgical Inc. 24.66% 24.34% 24.21% 25.35% 27.05% 28.48% 30.69% 31.89% 32.55% 31.27% 26.01% 24.09% 23.95% 25.86% 30.52% 30.69%
Medtronic PLC 18.17% 19.02% 19.37% 18.15% 17.89% 16.68% 14.78% 14.89% 11.44% 12.77% 14.25% 16.57% 20.67% 20.47% 21.25% 20.51%
UnitedHealth Group Inc. 8.86% 8.83% 8.87% 8.83% 8.65% 8.32% 8.19% 8.40% 7.91% 7.73% 9.24% 8.76% 9.55% 9.89% 8.12% 8.19%

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Operating profit margin = 100 × (Operating income (loss)Q3 2023 + Operating income (loss)Q2 2023 + Operating income (loss)Q1 2023 + Operating income (loss)Q4 2022) ÷ (RevenueQ3 2023 + RevenueQ2 2023 + RevenueQ1 2023 + RevenueQ4 2022)
= 100 × (205,500 + 128,100 + 47,200 + 125,400) ÷ (975,000 + 871,300 + 741,500 + 815,200) = 14.88%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. DexCom Inc. operating profit margin ratio improved from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.

Net Profit Margin

DexCom Inc., net profit margin calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in thousands)
Net income (loss) 120,700 115,900 48,600 91,800 101,200 50,900 97,300 (19,400) 70,900 62,900 40,300 355,200 72,200 46,300 19,900 92,700 45,800 (10,500) (26,900) (179,700) 46,600 30,200 (24,200)
Revenue 975,000 871,300 741,500 815,200 769,600 696,200 628,800 698,200 650,200 595,100 505,000 568,900 500,900 451,800 405,100 462,800 396,300 336,400 280,500 338,000 266,700 242,500 184,400
Profitability Ratio
Net profit margin1 11.08% 11.18% 9.68% 11.73% 8.24% 7.47% 8.23% 6.32% 22.82% 24.45% 25.36% 25.62% 12.69% 11.93% 9.24% 6.85% -12.68% -13.96% -11.51% -12.32%
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories 12.92% 12.83% 13.98% 15.88% 17.52% 18.78% 17.35% 16.42% 17.12% 15.85% 15.33% 12.99% 10.50% 9.89% 11.15% 11.56%
Cigna Group 2.81% 3.59% 3.71% 3.72% 3.69% 3.08% 3.07% 3.11% 4.97% 4.93% 5.22% 5.31% 3.40% 3.43% 3.22% 3.35%
CVS Health Corp. 2.48% 0.86% 1.20% 1.29% 1.00% 2.66% 2.68% 2.72% 2.67% 2.60% 2.74% 2.68% 3.00% 3.14% 2.77% 2.59%
Elevance Health Inc. 3.63% 3.89% 3.89% 3.87% 4.09% 4.13% 4.37% 4.46% 4.17% 3.32% 3.82% 3.78% 4.26% 5.27% 4.42% 4.66%
Humana Inc. 2.97% 3.45% 3.28% 3.03% 3.07% 3.52% 3.52% 3.54% 3.31% 3.13% 4.78% 4.43% 5.67% 5.00% 3.89% 4.20%
Intuitive Surgical Inc. 22.14% 21.38% 20.40% 21.25% 22.52% 24.05% 27.84% 29.85% 30.78% 31.43% 25.78% 24.33% 24.45% 26.07% 30.11% 30.80%
Medtronic PLC 13.20% 14.03% 16.75% 15.90% 15.46% 14.79% 12.29% 11.97% 10.36% 12.69% 15.80% 16.56% 17.11% 15.11% 14.41% 15.16%
UnitedHealth Group Inc. 6.09% 6.11% 6.21% 6.25% 6.21% 5.99% 5.91% 6.06% 5.56% 5.37% 6.46% 6.03% 6.66% 6.94% 5.63% 5.76%

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Net profit margin = 100 × (Net income (loss)Q3 2023 + Net income (loss)Q2 2023 + Net income (loss)Q1 2023 + Net income (loss)Q4 2022) ÷ (RevenueQ3 2023 + RevenueQ2 2023 + RevenueQ1 2023 + RevenueQ4 2022)
= 100 × (120,700 + 115,900 + 48,600 + 91,800) ÷ (975,000 + 871,300 + 741,500 + 815,200) = 11.08%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. DexCom Inc. net profit margin ratio improved from Q1 2023 to Q2 2023 but then slightly deteriorated from Q2 2023 to Q3 2023.

Return on Equity (ROE)

DexCom Inc., ROE calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in thousands)
Net income (loss) 120,700 115,900 48,600 91,800 101,200 50,900 97,300 (19,400) 70,900 62,900 40,300 355,200 72,200 46,300 19,900 92,700 45,800 (10,500) (26,900) (179,700) 46,600 30,200 (24,200)
Stockholders’ equity 2,267,900 2,100,400 2,233,000 2,131,800 1,824,500 2,255,900 2,189,300 2,251,500 2,136,100 1,997,600 1,903,200 1,826,500 1,499,300 1,353,900 934,500 882,600 764,300 688,300 668,600 663,300 562,200 482,100 421,700
Profitability Ratio
ROE1 16.62% 17.02% 13.10% 16.01% 12.61% 8.85% 9.67% 6.87% 24.78% 26.56% 27.01% 27.02% 15.41% 15.12% 15.83% 11.45% -22.41% -24.77% -19.41% -19.16%
Benchmarks
ROE, Competitors2
Abbott Laboratories 13.77% 13.88% 15.68% 18.90% 22.11% 23.44% 21.82% 19.75% 21.04% 18.86% 17.06% 13.71% 10.78% 10.17% 11.84% 11.86%
Cigna Group 11.61% 14.64% 15.17% 14.86% 14.69% 11.94% 11.69% 11.39% 17.68% 16.73% 17.52% 16.81% 11.03% 11.11% 10.91% 11.26%
CVS Health Corp. 11.57% 4.02% 5.57% 5.84% 4.46% 10.86% 10.83% 10.54% 10.20% 9.83% 10.44% 10.35% 11.56% 12.14% 11.08% 10.39%
Elevance Health Inc. 15.82% 16.78% 16.62% 16.59% 17.26% 17.04% 17.36% 16.93% 15.44% 12.10% 13.92% 13.77% 14.61% 17.17% 15.08% 15.15%
Humana Inc. 17.79% 20.07% 18.79% 18.33% 17.27% 20.29% 19.81% 18.24% 16.44% 16.72% 26.23% 24.53% 26.34% 24.29% 21.16% 22.49%
Intuitive Surgical Inc. 12.10% 12.00% 11.70% 11.98% 11.97% 11.93% 13.58% 14.32% 14.80% 14.97% 11.56% 10.90% 11.38% 13.00% 16.30% 16.69%
Medtronic PLC 7.90% 8.33% 9.88% 9.59% 9.35% 9.05% 7.54% 7.01% 5.70% 7.05% 8.77% 9.44% 10.26% 9.23% 8.78% 9.25%
UnitedHealth Group Inc. 25.67% 25.63% 25.46% 25.87% 26.03% 25.07% 23.98% 24.09% 21.95% 21.03% 25.42% 23.52% 25.65% 26.87% 24.14% 24.02%

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
ROE = 100 × (Net income (loss)Q3 2023 + Net income (loss)Q2 2023 + Net income (loss)Q1 2023 + Net income (loss)Q4 2022) ÷ Stockholders’ equity
= 100 × (120,700 + 115,900 + 48,600 + 91,800) ÷ 2,267,900 = 16.62%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. DexCom Inc. ROE improved from Q1 2023 to Q2 2023 but then slightly deteriorated from Q2 2023 to Q3 2023.

Return on Assets (ROA)

DexCom Inc., ROA calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in thousands)
Net income (loss) 120,700 115,900 48,600 91,800 101,200 50,900 97,300 (19,400) 70,900 62,900 40,300 355,200 72,200 46,300 19,900 92,700 45,800 (10,500) (26,900) (179,700) 46,600 30,200 (24,200)
Total assets 6,596,200 6,820,700 5,515,900 5,391,700 4,899,200 5,217,400 5,057,000 4,863,600 4,775,900 4,503,800 4,389,800 4,290,500 3,833,200 3,521,800 2,447,900 2,395,000 2,185,700 2,065,900 1,974,000 1,916,000 1,114,300 1,007,500 896,800
Profitability Ratio
ROA1 5.72% 5.24% 5.30% 6.33% 4.69% 3.83% 4.19% 3.18% 11.08% 11.78% 11.71% 11.50% 6.03% 5.81% 6.04% 4.22% -7.84% -8.25% -6.58% -6.63%
Benchmarks
ROA, Competitors2
Abbott Laboratories 7.16% 7.04% 7.87% 9.31% 10.84% 11.53% 10.44% 9.40% 9.82% 8.70% 7.86% 6.20% 4.90% 4.52% 5.36% 5.43%
Cigna Group 3.54% 4.43% 4.56% 4.63% 4.59% 3.59% 3.53% 3.46% 5.44% 5.29% 5.55% 5.44% 3.31% 3.30% 3.18% 3.28%
CVS Health Corp. 3.42% 1.17% 1.66% 1.82% 1.36% 3.55% 3.43% 3.39% 3.23% 3.12% 3.22% 3.11% 3.41% 3.51% 3.13% 2.98%
Elevance Health Inc. 5.50% 5.87% 5.69% 5.86% 6.03% 6.05% 6.21% 6.26% 5.63% 4.40% 4.93% 5.28% 5.72% 6.72% 5.80% 6.21%
Humana Inc. 5.39% 5.98% 5.69% 6.52% 5.53% 6.71% 6.55% 6.61% 5.90% 6.52% 9.95% 9.63% 10.79% 9.11% 7.55% 9.31%
Intuitive Surgical Inc. 10.31% 10.25% 10.05% 10.19% 10.39% 10.47% 12.02% 12.58% 13.06% 13.20% 10.17% 9.50% 9.92% 11.24% 14.02% 14.17%
Medtronic PLC 4.32% 4.63% 5.79% 5.54% 5.35% 5.13% 4.23% 3.87% 2.97% 3.69% 4.70% 5.28% 5.73% 5.13% 4.84% 5.16%
UnitedHealth Group Inc. 7.69% 7.53% 7.30% 8.19% 7.99% 7.93% 7.89% 8.15% 7.24% 6.90% 8.23% 7.81% 8.76% 8.88% 7.27% 7.96%

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
ROA = 100 × (Net income (loss)Q3 2023 + Net income (loss)Q2 2023 + Net income (loss)Q1 2023 + Net income (loss)Q4 2022) ÷ Total assets
= 100 × (120,700 + 115,900 + 48,600 + 91,800) ÷ 6,596,200 = 5.72%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. DexCom Inc. ROA deteriorated from Q1 2023 to Q2 2023 but then improved from Q2 2023 to Q3 2023 exceeding Q1 2023 level.